Drug profile · INN
dabrafenib mesylate
TAFINLAR
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
dabrafenib mesylate (TAFINLAR) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN dabrafenib mesylate
Brand TAFINLAR
Route ORAL
Formulation CAPSULE
Frequently asked questions
What is dabrafenib mesylate?
dabrafenib mesylate (TAFINLAR) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for dabrafenib mesylate?
TAFINLAR is a marketed brand name for dabrafenib mesylate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of dabrafenib mesylate?
dabrafenib mesylate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.